Association between adherence to concomitant proton pump inhibitor therapy in current NSAID users and upper gastrointestinal complications
Author(s) -
Christian Jonasson,
Jan Gunnar Hatlebakk,
Lars Lundell,
Jukka Pekka Kouri,
Morten Andersen,
Fredrik Granath
Publication year - 2012
Publication title -
european journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.881
H-Index - 102
eISSN - 1473-5687
pISSN - 0954-691X
DOI - 10.1097/meg.0b013e32835d5acd
Subject(s) - medicine , odds ratio , proton pump inhibitor , concomitant , medical prescription , confidence interval , observational study , population , logistic regression , peptic , gastroenterology , peptic ulcer , pharmacology , environmental health
Proton pump inhibitors (PPIs) play a well-documented role as a gastroprotective agent among NSAID users at an increased risk of peptic ulcer and bleeding. Observational studies have, however, suggested that the clinical efficacy of PPI therapy may be reduced because of poor adherence.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom